# A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee

> **NCT02024529** · PHASE3 · COMPLETED · sponsor: **Ampio Pharmaceuticals. Inc.** · enrollment: 538 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **BIOLOGICAL:** 4 mL injection of Ampion
- **DRUG:** 4 mL Injection of Placebo

## Key facts

- **NCT ID:** NCT02024529
- **Lead sponsor:** Ampio Pharmaceuticals. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-07
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024529, "A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02024529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*